Access to anti-retroviral drugs, male in Venezuela, Bolivarian Republic of
Venezuela, Bolivarian Republic of: Access to anti-retroviral drugs, male was 59.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Venezuela, Bolivarian Republic of, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Venezuela, Bolivarian Republic of is 59.0%, measured in 2024.
The figure is down 7.8% on the previous year and up 34.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Venezuela, Bolivarian Republic of peaked at 65.0% in 2020 and was at its lowest, 2.0%, in 2000.
Venezuela, Bolivarian Republic of ranks 105th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Venezuela, Bolivarian Republic of, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 2.0% | — |
| 2001 | 5.0% | +150.0% |
| 2002 | 7.0% | +40.0% |
| 2003 | 9.0% | +28.6% |
| 2004 | 10.0% | +11.1% |
| 2005 | 12.0% | +20.0% |
| 2006 | 19.0% | +58.3% |
| 2007 | 22.0% | +15.8% |
| 2008 | 27.0% | +22.7% |
| 2009 | 33.0% | +22.2% |
| 2010 | 39.0% | +18.2% |
| 2011 | 41.0% | +5.1% |
| 2012 | 44.0% | +7.3% |
| 2013 | 44.0% | +0.0% |
| 2014 | 44.0% | +0.0% |
| 2015 | 57.0% | +29.5% |
| 2016 | 52.0% | -8.8% |
| 2017 | 41.0% | -21.2% |
| 2018 | 28.0% | -31.7% |
| 2019 | 51.0% | +82.1% |
| 2020 | 65.0% | +27.5% |
| 2021 | 64.0% | -1.5% |
| 2024 | 59.0% | -7.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.6% | 2.0% | 33.0% | 10 |
| 2010s | 44.1% | 28.0% | 57.0% | 10 |
| 2020s | 62.7% | 59.0% | 65.0% | 3 |
Countries ranked near Venezuela, Bolivarian Republic of
- 102 Albania 60.0% compare
- 102 Maldives 60.0% compare
- 102 North Macedonia 60.0% compare
- 105 Bolivia, Plurinational State of 59.0% compare
- 105 Malaysia 59.0% compare
- 105 Syrian Arab Republic 59.0% compare
More gender data for Venezuela, Bolivarian Republic of
- Child population (UN estimates and projections) 6,517 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.32 % change on previous year (2030)
- Population 22,635 (2030)
- Working-age population (UN estimates and projections) 22,635 (2030)
- Population (UN estimates and projections), annual growth rate 1 % change on previous year (2030)
- Age population, age 00, female, interpolated 207,912 (2025)
- Age population, age 00, male, interpolated 218,340 (2025)
- Age population, age 01, female, interpolated 204,155 (2025)
- Age population, age 01, male, interpolated 214,388 (2025)
- Age population, age 02, female, interpolated 200,986 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Venezuela, Bolivarian Republic of?
- Access to anti-retroviral drugs, male in Venezuela, Bolivarian Republic of was 59.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Venezuela, Bolivarian Republic of?
- The highest recorded value was 65.0% in 2020.
- What is the lowest access to anti-retroviral drugs, male recorded in Venezuela, Bolivarian Republic of?
- The lowest recorded value was 2.0% in 2000.
- How does Venezuela, Bolivarian Republic of rank for access to anti-retroviral drugs, male?
- Venezuela, Bolivarian Republic of ranks 105th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Venezuela, Bolivarian Republic of?
- Over the last ten years it is up 34.1%. The long-run trend across the full record is volatile.
- Where does this Venezuela, Bolivarian Republic of data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.